The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Apoptosis Regulator BAX - Drugs In Development, 2021
US$ 3,500.00
Apoptosis Regulator BAX - Drugs In Development, 2021 SUMMARY Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded b...
June 2021
46 pages
Arrhythmias (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Arrhythmias (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias (Cardiovascular) - Drugs In Developmen...
June 2021
92 pages
Aryl Hydrocarbon Receptor - Drugs In Development, 2021
US$ 3,500.00
Aryl Hydrocarbon Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Aryl Hydrocarbon Receptor - Drugs In Development, 2021'; Aryl Hydrocarbon Receptor (Class E B...
June 2021
139 pages
Burns (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Burns (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burns (Dermatology) - Drugs In Development, 2021, provides...
June 2021
142 pages
Caspase 7 - Drugs In Development, 2021
US$ 3,500.00
Caspase 7 - Drugs In Development, 2021 SUMMARY Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Caspase-7 (CASP7) is a human protein encoded by...
June 2021
56 pages
Dystrophin (DMD) - Drugs In Development, 2021
US$ 3,500.00
Dystrophin (DMD) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Dystrophin - Drugs In Development, 2021'; Dystrophin (DMD) pipeline Target constitutes close to 57 mol...
June 2021
161 pages
Exportin 1 - Drugs In Development, 2021
US$ 3,500.00
Exportin 1 - Drugs In Development, 2021 SUMMARY Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 mo...
June 2021
143 pages
Gonorrhea (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Gonorrhea (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea (Infectious Disease) - Drugs In Develo...
June 2021
127 pages
Gorlin Syndrome (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Gorlin Syndrome (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Oncology) - Drugs In Development, 2...
June 2021
186 pages
Iduronate 2 Sulfatase - Drugs In Development, 2021
US$ 3,500.00
Iduronate 2 Sulfatase - Drugs In Development, 2021 SUMMARY According to the recently published report 'Iduronate 2 Sulfatase - Drugs In Development, 2021'; Iduronate 2 Sulfatase (Alpha L Iduronate Sul...
June 2021
75 pages
Leukotriene A 4 Hydrolase - Drugs In Development, 2021
US$ 3,500.00
Leukotriene A 4 Hydrolase - Drugs In Development, 2021 SUMMARY Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 mol...
June 2021
50 pages
Myocarditis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Myocarditis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Developmen...
June 2021
57 pages
